» Articles » PMID: 37510309

APOE Gene Associated with Dementia-Related Traits, Depression, and Anxiety in the Hispanic Population

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2023 Jul 29
PMID 37510309
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD), a main cause of dementia, is commonly seen in aging populations with a strong genetic component. AD is one of the most common neurodegenerative disorders; it is a genetically and clinically heterogeneous disease. Specific demographic factors and genetic variants have been identified in non-Hispanic populations; however, limited studies have observed the Hispanic population. Therefore, we focused on investigating a known gene, APOE, associated with AD-related phenotypes and two psychiatric diseases (depression and anxiety) within the U.S. Hispanic population in our current study. A total of 1382 subjects were studied based on data collected from the Texas Alzheimer's Research and Care Consortium (TARCC, = 1320) and the Initial Study of Longevity and Dementia from the Rio Grande Valley (ISLD-RGV, = 62). Questionnaires regarding demographics, medical history, and blood/saliva samples were collected. We genotyped the APOE gene. The current findings indicated that APOE-ε4 was associated with not only AD ( < 0.0001) but also with anxiety ( < 0.0001) and depression ( = 0.0004). However, APOE-ε3 was associated with depression ( = 0.002) in the Hispanic population. We provide additional evidence in which APOE-ε4 increased the risk for AD in Hispanics. For the first time, APOE alleles show increased risks for anxiety and depression in Hispanics. Further research is warranted to confirm the current findings.

Citing Articles

The novel estrogen receptor beta agonist EGX358 and genotype influence memory, vasomotor, and anxiety outcomes in an Alzheimer's mouse model.

Schwabe M, Fleischer A, Kuehn R, Chaudhury S, York J, Sem D Front Aging Neurosci. 2024; 16:1477045.

PMID: 39629477 PMC: 11613887. DOI: 10.3389/fnagi.2024.1477045.


Are Ischemic Stroke and Alzheimer's Disease Genetically Consecutive Pathologies?.

Filippenkov I, Khrunin A, Mozgovoy I, Dergunova L, Limborska S Biomedicines. 2023; 11(10).

PMID: 37893101 PMC: 10604604. DOI: 10.3390/biomedicines11102727.

References
1.
Feng F, Lu S, Hu C, Gong F, Qian Z, Yang H . Association between apolipoprotein E gene polymorphism and depression. J Clin Neurosci. 2015; 22(8):1232-8. DOI: 10.1016/j.jocn.2015.02.012. View

2.
Blue E, Horimoto A, Mukherjee S, Wijsman E, Thornton T . Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics. Alzheimers Dement. 2019; 15(12):1524-1532. PMC: 6925639. DOI: 10.1016/j.jalz.2019.07.016. View

3.
Camacho A, Tarraf W, Jimenez D, Gallo L, Gonzalez P, Kaplan R . Anxious Depression and Neurocognition among Middle-Aged and Older Hispanic/Latino Adults: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Results. Am J Geriatr Psychiatry. 2017; 26(2):238-249. PMC: 5752627. DOI: 10.1016/j.jagp.2017.06.002. View

4.
Zhao Q, Tan L, Wang H, Jiang T, Tan M, Tan L . The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis. J Affect Disord. 2015; 190:264-271. DOI: 10.1016/j.jad.2015.09.069. View

5.
Lyketsos C, Carrillo M, Ryan J, Khachaturian A, Trzepacz P, Amatniek J . Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement. 2011; 7(5):532-9. PMC: 3299979. DOI: 10.1016/j.jalz.2011.05.2410. View